HCP, Inc. (NYSE:HCP) has received an average recommendation of “Buy” from the fifteen brokerages that are covering the firm, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $30.88.
Several equities analysts recently weighed in on the stock. Zacks Investment Research upgraded shares of HCP from a “sell” rating to a “hold” rating in a report on Thursday, March 14th. Morgan Stanley set a $32.00 price objective on shares of HCP and gave the company a “hold” rating in a report on Thursday, March 28th. Raymond James upgraded shares of HCP from a “market perform” rating to an “outperform” rating and set a $35.00 price objective on the stock in a report on Thursday, June 13th. Finally, TheStreet lowered shares of HCP from a “b-” rating to a “c+” rating in a report on Tuesday, May 7th.
In other HCP news, Director Christine Garvey sold 3,405 shares of the company’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $29.80, for a total value of $101,469.00. Following the completion of the sale, the director now owns 5,348 shares of the company’s stock, valued at $159,370.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.13% of the stock is currently owned by corporate insiders.
A number of large investors have recently modified their holdings of HCP. Pacific Center for Financial Services increased its position in shares of HCP by 123.5% during the fourth quarter. Pacific Center for Financial Services now owns 894 shares of the real estate investment trust’s stock worth $25,000 after acquiring an additional 494 shares in the last quarter. Massey Quick Simon & CO. LLC bought a new stake in shares of HCP during the first quarter worth $25,000. Executive Wealth Management LLC bought a new stake in shares of HCP during the fourth quarter worth $30,000. Rational Advisors LLC increased its position in shares of HCP by 336.7% during the fourth quarter. Rational Advisors LLC now owns 1,262 shares of the real estate investment trust’s stock worth $35,000 after acquiring an additional 973 shares in the last quarter. Finally, Pearl River Capital LLC bought a new stake in shares of HCP during the fourth quarter worth $35,000. 95.47% of the stock is owned by hedge funds and other institutional investors.
Shares of HCP stock traded down $0.09 during trading hours on Tuesday, reaching $32.71. 117,787 shares of the company were exchanged, compared to its average volume of 3,434,701. HCP has a fifty-two week low of $24.47 and a fifty-two week high of $33.58. The business has a fifty day moving average price of $31.54. The firm has a market cap of $15.68 billion, a P/E ratio of 18.02, a price-to-earnings-growth ratio of 7.11 and a beta of 0.31. The company has a debt-to-equity ratio of 0.90, a quick ratio of 0.80 and a current ratio of 0.80.
HCP (NYSE:HCP) last announced its earnings results on Wednesday, May 1st. The real estate investment trust reported $0.44 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.43 by $0.01. HCP had a net margin of 59.96% and a return on equity of 18.05%. The company had revenue of $436.15 million for the quarter, compared to analyst estimates of $442.20 million. During the same period in the prior year, the business earned $0.48 earnings per share. HCP’s quarterly revenue was down 9.0% on a year-over-year basis. As a group, sell-side analysts predict that HCP will post 1.74 EPS for the current year.
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Further Reading: Buy Rating
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.